Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates

Calcified Tissue International

Volumn 69, Issue 4, 2001, Pages 252-255

  Ringe, J D ^a   Rovati, L C ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Rotta Research Laboratorium   (Italy)

Author keywords

Alendronate; Contractions; Fluoride; Male osteoporosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ETIDRONIC ACID; FLUORIDE; VITAMIN D;

BONE DENSITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG INTERMITTENT THERAPY; FRACTURE; HUMAN; MALE; OSTEOPOROSIS; PRIORITY JOURNAL;

ALENDRONATE; BONE AND BONES; BONE DENSITY; CLIMACTERIC; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; FLUORIDES; HUMANS; MALE; OSTEOPOROSIS; PILOT PROJECTS;

EID: 0034762411     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-001-1050-x     Document Type: Conference Paper

References (25)

1. The economic and human costs of osteoporotic fracture
2. Hip fractures in the elderly: A worldwide projection
3. The prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporosis Study
4. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism
5. Effects of testosterone replacement in hypogonadal men
6. Effect of testosterone treatment on bone mineral density in men over 65 years of age
7. The prevention and therapy of osteoporosis in men
8. Treatment of metabolic bone disease
9. Alendronate for the treatment of osteoporosis in men
10. Alendronate treatment of established primary osteoporosis in men: Two-year results of a prospective comparative two-arm study
11. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers
12. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three-year therapy with calcium and low-dose intermittent monofluorophosphate
13. Stimulators of bone formation for the treatment of osteoporosis
14. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial
15. Effect of Fluoride/Calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis
16. Effects of low-dose monofluorophosphate and transdermal oestradiol on postmenopausal vertebral bone loss
17. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: A randomized study
18. Combined osteoanabolic-antiresorptive treatment of established postmenopausal osteoporosis with monofluorophosphate/calcium and hormone replacement therapy
19. Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticoid induced osteoporosis?
20. Fluoride for the treament of postmenopausal osteoporosis
21. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
22. Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis
23. What is proven about hip fracture rate and fluoride treatment?
24. Antiosteoporotic therapy with monofluorophosphate and calcium increases cortical and trabecular vertebral bone density
25. Calcium deficiency in fluoride-treated osteoporotic patients despite calcium supplementation